Advertise
Resources
Member, Beacon International Group, Ltd.
Screenings for a variety of common cancers have not returned to pre-pandemic levels, potentially leading to diagnoses later in the course of the disease when it may be more difficult to treat successfully, reports Reuters. In 2020 – the first year of the pandemic – average rates of screening for breast cancer fell by 40%, for cervical cancer by 36%, and for colorectal cancer by 45%, compared to the three previous years, according to an analysis of medical claims data from 306 million adults.